RESUMO
To date the association between mucopolysaccharidosis (MPS) IIIA and precocious puberty has been found in only three polish patients. We observed two children affected by MPS IIIA with central precocious puberty (CPP) both treated with GnRH agonists. The occurrence of CPP in both patients with MPS IIIA suggests that it is necessary to look for an association between the two conditions. The follow-up of our two patients leads us to believe also that GnRH agonist treatment can have a beneficial effect on final height and probably on the improvement of behavioural problems.
Assuntos
Mucopolissacaridose III/complicações , Mucopolissacaridose III/diagnóstico , Mutação , Puberdade Precoce/complicações , Adolescente , Estatura/efeitos dos fármacos , Encéfalo/patologia , Criança , Transtornos do Comportamento Infantil/complicações , Transtornos do Comportamento Infantil/tratamento farmacológico , Análise Mutacional de DNA , Hormônio Liberador de Gonadotropina/agonistas , Humanos , Luteolíticos/uso terapêutico , Imageamento por Ressonância Magnética/métodos , Masculino , Mucopolissacaridose III/patologia , Puberdade Precoce/diagnóstico , Puberdade Precoce/tratamento farmacológico , Pamoato de Triptorrelina/uso terapêuticoRESUMO
Mucopolysaccharidosis IVA is an autosomal recessive disease caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Mutation screening of the GALNS gene was performed for seven MPS IVA patients with attenuated phenotypes from three unrelated families. Four of 5 missense mutations identified in this study (p.F167V, p.R253W, p.R380S, p.P484S) and two reported (p.F97V, p.N204K), associated with attenuated phenotypes, were characterized using in vitro stable expression experiments, enzyme kinetic study, protein processing and structural analysis. The stably expressed mutant enzymes defining the attenuated phenotype exhibited a considerable residual activity (1.2-36.7% of the wild-type GALNS activity) except for p.R380S. Enzyme kinetic studies showed that p.F97V, p.F167V and p.N204K have lower affinity to the substrate compared with other mutants. The p.F97V enzyme was the most thermolabile at 55 degrees C. Immunoblot analyses indicated a rapid degradation and/or an insufficiency in processing in the mutant proteins. Tertiary structure analysis revealed that although there was a tendency for 'attenuated' mutant residues to be located on the surface of GALNS, they have a different effect on the protein including modification of the hydrophobic core and salt-bridge formation and different potential energy. This study demonstrates that 'attenuated' mutant enzymes are heterogeneous in molecular phenotypes, including biochemical properties and tertiary structure.
Assuntos
Condroitina Sulfatases/genética , Mucopolissacaridose IV/genética , Mutação de Sentido Incorreto , Adolescente , Adulto , Animais , Células CHO , Condroitina Sulfatases/química , Condroitina Sulfatases/deficiência , Condroitina Sulfatases/metabolismo , Cricetinae , Cricetulus , Análise Mutacional de DNA , Estabilidade Enzimática , Éxons , Feminino , Predisposição Genética para Doença , Temperatura Alta , Humanos , Interações Hidrofóbicas e Hidrofílicas , Itália , Japão , Cinética , Masculino , Pessoa de Meia-Idade , Modelos Moleculares , Mucopolissacaridose IV/enzimologia , Paquistão , Linhagem , Fenótipo , Processamento de Proteína Pós-Traducional , Estrutura Terciária de Proteína , Índice de Gravidade de Doença , Especificidade por Substrato , TransfecçãoRESUMO
Mucopolysaccharidosis type I (MPS I) due to deficient alpha-L-iduronidase (IDUA) activity results in the accumulation of glycosaminoglycans (GAGs) in many of the cells of affected patients. Stable gene replacement by in vivo administration of lentiviral vectors (LVs) has therapeutic potential for metabolic disorders and other systemic diseases. We have previously shown in a murine model the therapeutic potential of lentiviral IDUA vector-mediated gene therapy, in which human IDUA cDNA was driven by the cytomegalovirus promoter. However, the major limitation of this approach was the induction of an immune response against the therapeutic protein, which limited the efficacy and long-term duration of treatment. In this study, we evaluate the potential of liver-directed gene therapy, that is, programming of murine hepatocytes to secrete the enzyme with mannose 6-phosphate (M6P), which can be taken up by distant cells. Eight- to 10-week-old mice were injected via the tail vein with a lentiviral vector expressing human IDUA cDNA driven by the albumin gene promoter selectively expressed in hepatocytes. One month after treatment, IDUA activity was present in the liver and spleen of treated mice; an expression level of 1% normal IDUA activity was sufficient to reduce the GAG level in liver, spleen, kidney, heart, and lung. Interestingly, 6 months after a single injection of this vector, IDUA activity was detectable in several murine tissues; the level of enzyme activity was low but sufficient to maintain the decrease in GAG levels in liver, spleen, kidney, heart, and lung. Also, the level of enzyme-specific antibodies reached at 6 months postinjection was nearly null, and real-time polymerase chain reaction analysis showed high levels of vector DNA content in liver and spleen. Thus, these results show that the use of LV with the albumin gene promoter selectively expressed in hepatocytes limited the immune response to the transgene and allowed stable and prolonged expression of the IDUA enzyme and a partial correction of the pathology.
Assuntos
Terapia Genética , Vetores Genéticos/uso terapêutico , Iduronidase/genética , Fígado/enzimologia , Mucopolissacaridose I/terapia , Transgenes/genética , Animais , Formação de Anticorpos , Autoanticorpos/sangue , Humanos , Iduronidase/biossíntese , Iduronidase/imunologia , Lentivirus/genética , Camundongos , Mucopolissacaridose I/enzimologia , Mucopolissacaridose I/genética , Especificidade de Órgãos , Reação em Cadeia da Polimerase , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/uso terapêutico , Baço/enzimologia , Fatores de TempoRESUMO
The major enzyme component of iduronate sulfatase from human placenta was purified 30 000-fold by a five-step procedure. Sucrose gradient centrifugation of the native enzyme gave a molecular weight estimate of 80 000 +/- 10 000. Electrophoresis in sodium dodecyl sulfate of the enzyme reduced with mercaptoethanol showed a protein band of Mr 82 000. We suggest that the enzyme is composed of a single polypeptide chain of Mr 80 000-90 000.
Assuntos
Iduronato Sulfatase/isolamento & purificação , Placenta/enzimologia , Sulfatases/isolamento & purificação , Feminino , Humanos , Peso Molecular , GravidezRESUMO
Iduronate sulfatase of human placenta separates on DEAE Bio-Gel A chromatography into two components, a less acidic form A and a more acidic form B. The two forms have different mobilities on gel electrophoresis and different isoelectric points, pH 5.0 for form A and pH 4.5 for form B. They show the same pH optima in sodium acetate buffer and similar Km values for [3H]disulfated disaccharide substrate. Iduronate sulfatase A is more heat labile than iduronate sulfatase B. Different molecular weights were found by gel filtration while similar values were estimated by sucrose gradient centrifugation. Neuraminidase treatment of the two forms gives evidence that these enzymes contain sialic acid residues.
Assuntos
Iduronato Sulfatase/isolamento & purificação , Placenta/enzimologia , Sulfatases/isolamento & purificação , Feminino , Temperatura Alta , Humanos , Iduronato Sulfatase/metabolismo , Ponto Isoelétrico , Cinética , Peso Molecular , GravidezRESUMO
Human lymphoblasts deficient in iduronate sulfatase or in alpha-N-acetylglucosaminidase acquire discrete levels of enzyme activity after co-culture with human normal skin fibroblasts. This occurs by direct cell-to-cell contact and not by uptake of secreted fibroblast enzyme. The process is dependent on time and on the number of fibroblasts used. Electron-microscopic examination of the co-culture of the two cell types reveals extensive region of intimate contact. Fibroblastic projections appear frequently in close apposition with lymphoblast invaginations; a diffuse micropinocytotic activity is evident only in fibroblastic cells.
Assuntos
Acetilglucosaminidase/metabolismo , Comunicação Celular , Fibroblastos/citologia , Iduronato Sulfatase/metabolismo , Linfócitos/citologia , Acetilglucosaminidase/deficiência , Transformação Celular Viral , Fibroblastos/enzimologia , Humanos , Linfócitos/enzimologia , Microscopia Eletrônica , Mucopolissacaridoses/enzimologia , Mucopolissacaridose IIRESUMO
Five point mutations (R88H, R88P, T118I, 959delT, R468Q) previously identified in the iduronate-2-sulfatase (IDS) gene of Italian Hunter patients were expressed in COS cells to evaluate their functional consequence on enzyme activity, processing and intracellular localization. The 88 arginine residue belongs to the CXPSR pentapeptide conserved in all human sulfatases, where cysteine modification to formylglycine is required for enzyme activity. Substitution of arginine with histidine residue resulted in 13.7% residual enzyme activity, with an apparent K(m) value (133 microM) lower than that found for the normal enzyme (327 microM), indicating a higher affinity for the substrate; substitution of arginine with proline resulted in total absence of residual activity, in agreement with the phenotypes observed in patients carrying R88H and R88P mutations. For the four missense mutations, pulse-chase labelling experiments showed an apparently normal maturation; however, subcellular fractionation demonstrated poor transport to lysosomes. Therefore, residues 88, 118 and 468 appear to be not essential for processing but important for IDS conformation.
Assuntos
Iduronato Sulfatase/genética , Mucopolissacaridose II/genética , Mutação Puntual , Animais , Células COS , Fracionamento Celular , Humanos , Iduronato Sulfatase/metabolismo , Imunoensaio , Itália , Cinética , Lisossomos/metabolismo , Mutagênese Sítio-Dirigida , Conformação Proteica , RNA Mensageiro/análise , Proteínas Recombinantes , TransfecçãoRESUMO
Mucopolysaccharidosis type II (Hunter syndrome; OMIM 309900) is a rare X-linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS; EC 3.1.6.13). Different alterations at the IDS locus, mostly missense mutations, have been demonstrated, by expression study, as deleterious, causing significant consequences on the enzyme function or stability. In the present study we report on the results of the transient expression of the novel K347T, 533delTT, N265I and the already described 473delTCC (previously named DeltaS117) mutations in the COS 7 cells proving their functional consequence on IDS activity. This type of information is potentially useful for genotype-phenotype correlation, prognosis and possible therapeutic intervention.
Assuntos
Iduronato Sulfatase/genética , Mucopolissacaridose II/genética , Animais , Células COS , DNA Complementar/biossíntese , Humanos , Iduronato Sulfatase/biossíntese , Immunoblotting , Mucopolissacaridose II/enzimologia , Mutagênese Sítio-Dirigida , Mutação , TransfecçãoRESUMO
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a congenital storage disorder resulting from mutations on the iduronate-2-sulfatase (IDS) gene. The disease shows variable clinical phenotypes from severe to mild with progressive neurological dysfunction. The therapeutic options for treatment of MPS II are limited and currently no specific therapies are available; the problem is further compounded by difficulties in delivering therapeutic agents to the central nervous system (CNS). In this work, as a potential treatment for this disease, the transfer of the recombinant IDS enzyme into brain cells has been studied in vitro. Two different approaches to obtain recombinant IDS have been utilized: production of the recombinant enzyme by a transfected human clone (Bosc 23 cells); production of the recombinant enzyme by adenoviral transduction of neuronal (SK-N-BE) or glial (C6) cells. Our data indicate that the transfected as well as the infected cells produce a large amount of the IDS enzyme, which is efficiently endocytosed into neuronal and glial cells through the mannose 6-phosphate (M6P) receptor system. Somatic gene therapy appears therefore to be suitable to correct IDS deficiency in brain cells.
Assuntos
Iduronato Sulfatase/metabolismo , Neuroglia/metabolismo , Neurônios/metabolismo , Adenoviridae/genética , Animais , Linhagem Celular , Células Clonais , Endocitose , Humanos , Iduronato Sulfatase/biossíntese , Iduronato Sulfatase/genética , Lisossomos/metabolismo , Testes de Precipitina , Ratos , Transdução Genética , TransfecçãoRESUMO
Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI, MPS VI) is an autosomal recessive disorder due to the deficiency of the lysosomal enzyme N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ASB). Mutation analysis in Maroteaux-Lamy syndrome resulted in the identification of approximately 40 molecular defects underlying a great genetic heterogeneity. Here we report five novel mutations in Italian subjects: S65F, P116H, R315Q, Q503X, P531R; each defect was confirmed by restriction enzyme or amplification refractory mutation system (ARMS) analysis. We also performed a three-dimensional (3-D) structure analysis of the alterations identified by us, and of an additional 22 point mutations reported by other groups, in an attempt to draw helpful information about their possible effects on protein conformation.
Assuntos
Mucopolissacaridose VI/genética , N-Acetilgalactosamina-4-Sulfatase/genética , Mutação Puntual , Sítios de Ligação , Criança , Éxons , Humanos , Lactente , Modelos Moleculares , N-Acetilgalactosamina-4-Sulfatase/química , Polimorfismo Conformacional de Fita Simples , Dobramento de ProteínaRESUMO
Sanfilippo syndrome type A or mucopolysaccharidosis IIIA (MPS IIIA) results from the deficiency of the enzyme heparan N-sulfatase (NS, EC 3.10.1.1), required for the degradation of heparan sulfate. Molecular defects of 24 Italian MPS IIIA patients were recently reported by our group. We report here two novel mutations: 1040insT and Q365X and the expression studies on 15 of the identified defects. Transient expression of COS cells by cDNA mutagenized to correspond to heparan N-sulfatase mutations Y40N, A44T, 166delG, G122R, P128L, L146P, R150Q, D179N, R182C, R206P, P227R, 1040insT, 1093insG, E369K, R377C did not yield active enzyme, demonstrating the deleterious nature of the mutations. Western blot analysis and metabolic labeling experiments revealed, for cells transfected with wild-type enzyme, a precursor 62-kDa form and a mature 56-kDa form. Western blot resulted, for 11 mutations, in the presence of both forms, indicating a normal maturation of the mutant enzyme. Western blot, metabolic labeling and immunofluorescence experiments suggested, for mutations 166delG, L146P, 1040insT and 1093insG, an increased degradation of the mutant enzymes.
Assuntos
Mucopolissacaridose III/genética , Sulfatases/genética , Animais , Sítios de Ligação/genética , Western Blotting , Células COS , DNA Complementar/metabolismo , Técnica Indireta de Fluorescência para Anticorpo , Expressão Gênica , Humanos , Itália/epidemiologia , Mucopolissacaridose III/epidemiologia , Mutagênese Sítio-Dirigida , Mutação , Polimorfismo Genético , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sulfatases/metabolismo , TransfecçãoRESUMO
B16-BL6 mouse melanoma cells cultured on fibronectin-coated dishes were detached by treatment with echistatin, an RGD-containing disintegrin. Echistatin was active at micromolar concentrations and was not cytotoxic. Its effect was dose-dependent and reversible. Sequential morphological changes leading to rounding up of the cells were detected by phase-contrast microscopy and by immunofluorescence analysis. A dramatic reduction in the number and size of focal adhesions and loss of cytoplasmic actin filaments were observed well before cell detachment occurred. Echistatin treatment down-regulated the phosphorylation of pp125FAK in fibronectin-adherent cells in a dose- and time-dependent fashion. The reduction of pp125FAK phosphorylation preceded cell detachment and occurred even in the presence of orthovanadate, an inhibitor of protein tyrosine phosphatases. These results suggest that echistatin detaches cells from the fibronectin substratum by inducing a decrease of pp125FAK phosphorylation and that echistatin acts by inhibiting protein tyrosine kinase activity rather than activating protein tyrosine phosphatases.
Assuntos
Citoesqueleto de Actina/efeitos dos fármacos , Moléculas de Adesão Celular/metabolismo , Adesão Celular/efeitos dos fármacos , Peptídeos/farmacologia , Proteínas Tirosina Quinases/metabolismo , Venenos de Víboras/farmacologia , Actinas/efeitos dos fármacos , Animais , Moléculas de Adesão Celular/química , Membrana Celular/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Fibronectinas/metabolismo , Quinase 1 de Adesão Focal , Proteína-Tirosina Quinases de Adesão Focal , Peptídeos e Proteínas de Sinalização Intercelular , Melanoma , Camundongos , Fosforilação , Fosfotirosina/análise , Proteínas Tirosina Fosfatases/antagonistas & inibidores , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/química , Células Tumorais Cultivadas , Vanadatos/farmacologiaRESUMO
Tay-Sachs disease is a lipidosis due to the deficiency of the lysosomal hexosaminidase A. In order to understand the molecular mechanisms of this enzyme deficiency we studied 42 patients of different ethnic origins diagnosed in Europe. The strategy used consists in HEXA cDNA amplification followed by allele-specific oligonucleotide analysis for the frequent mutations, and by chemical cleavage mismatch and denaturing gradient gel electrophoresis for the detection of new mutations. 90% of alleles were clarified in this way, showing a high heterogeneity of HEXA lesions in Tay-Sachs disease. 28 different mutations were found, 20 being identified for the first time in this group of patients.
Assuntos
Mutação , Doença de Tay-Sachs/epidemiologia , Doença de Tay-Sachs/genética , beta-N-Acetil-Hexosaminidases/genética , Adulto , Alelos , Composição de Bases , Sequência de Bases , Pré-Escolar , Análise Mutacional de DNA/métodos , Fosfatos de Dinucleosídeos/genética , Eletroforese em Gel de Poliacrilamida/métodos , Mutação da Fase de Leitura , Genótipo , Hexosaminidase A , Humanos , Lactente , Epidemiologia Molecular , Dados de Sequência Molecular , Mutagênese Insercional , Ácidos Nucleicos Heteroduplexes/genética , Sondas de Oligonucleotídeos , Fenótipo , Mutação Puntual , Splicing de RNA , Deleção de SequênciaRESUMO
Sulfatases are members of a highly conserved family of enzymes that catalyze the hydrolysis of sulfate ester bonds from a variety of substrates. The functional correlation reflects a high degree of amino acid sequence similarity along the entire length, in particular in the active site where the C(X)PSR consensus sequence is present. Cysteine undergoes an important co- or post-translation modification essential for the accomplishment of catalytic activity: conversion in formylglycine. In this work, the cysteine of heparan N-sulfatase (NS) was replaced either by a serine (C70S) or by a methionine (C70M) using site-directed mutagenesis. C70S and C70M mutant cDNAs were expressed and analyzed in COS cells; both mutations caused a loss of NS activity; however, while C70S showed a normal precursor form undergoing processing to a reduced mature form within the lysosomes, C70M was poorly synthesized and formed a complex with the molecular chaperone immunoglobulin binding protein.
Assuntos
Cisteína/metabolismo , Proteínas de Choque Térmico , Processamento de Proteína Pós-Traducional , Sulfatases/metabolismo , Animais , Sequência de Bases , Western Blotting , Células COS , Proteínas de Transporte/metabolismo , Catálise , Cisteína/genética , Primers do DNA , Chaperona BiP do Retículo Endoplasmático , Metionina/genética , Chaperonas Moleculares/metabolismo , Mutagênese Sítio-Dirigida , Ligação Proteica , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Sulfatases/química , Sulfatases/genéticaRESUMO
The adhesion of ADP-stimulated platelets to immobilized fibrinogen induces the tyrosine phosphorylation of multiple proteins which include pp72syk and pp125FAK. The phosphorylation of these two proteins increases as function of time of platelet adhesion to fibrinogen; however, pp72syk results strongly phosphorylated already after 15 min, whereas pp125FAK reaches high levels of phosphorylation after 1 h of platelet adhesion. Phosphorylation of both proteins is only slightly detectable when platelets are held in suspension or when platelets are allowed to adhere to bovine serum albumin, a non-specific substrate. Echistatin, an Arg-Gly-Asp (RGD)-containing snake-venom protein, affects protein tyrosine phosphorylation promoted by platelet adhesion to fibrinogen, by causing an approximately 44% and 39% decrease of pp72syk and pp125FAK phosphorylation, respectively. The interaction of echistatin with fibrinogen receptor glycoprotein IIb-IIIa on platelet surface might be responsible for the block of integrin-mediated signaling cascade, including pp72syk and pp125FAK inactivation.
Assuntos
Moléculas de Adesão Celular/farmacologia , Precursores Enzimáticos/antagonistas & inibidores , Fibrinogênio/metabolismo , Peptídeos/farmacologia , Adesividade Plaquetária/efeitos dos fármacos , Inibidores da Agregação Plaquetária/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/farmacologia , Plaquetas/enzimologia , Western Blotting , Moléculas de Adesão Celular/sangue , Eletroforese em Gel de Poliacrilamida , Precursores Enzimáticos/sangue , Quinase 1 de Adesão Focal , Proteína-Tirosina Quinases de Adesão Focal , Humanos , Peptídeos e Proteínas de Sinalização Intercelular , Peptídeos e Proteínas de Sinalização Intracelular , Fosforilação/efeitos dos fármacos , Testes de Precipitina , Proteínas Tirosina Quinases/sangue , Quinase SykRESUMO
A case of a child with Sanfilippo B syndrome (MPS III B), born of a consanguineous marriage, is reported. Urinary mucopolysaccharide analysis showed an abnormal excretion mainly of heparan sulphate. N-acetyl-a-glucosaminidase activity was absent in the patient but was present in the heterozygous range in parents and siblings. CSF mucopolysaccharides were also abnormally high. In fibrocytes from conjunctival biopsy and CSF cells numerous vacuoles containing storage material were found. The presence of vacuoles in fibrocytes from conjunctival biopsy and/or in CSF cells can be useful in the diagnosis of many suspected lysosomal storage disorders.
Assuntos
Mucopolissacaridoses/diagnóstico , Mucopolissacaridose III/diagnóstico , Acetilglucosaminidase/deficiência , Criança , Túnica Conjuntiva/patologia , Diagnóstico Diferencial , Glicosaminoglicanos/líquido cefalorraquidiano , Humanos , Masculino , Mucopolissacaridose III/genética , Mucopolissacaridose III/patologia , LinhagemRESUMO
Long-term lymphoblastoid cell lines have been established from a patient with Hunter syndrome, from his mother, an obligate heterozygote, and from several control individuals. Biochemical analyses show that lymphoblastoid cells represent a suitable biological material for the diagnosis of hemizygous, affected males and for heterozygous females: clonal analysis demonstrates the mosaicism predicted by the Lyon hypothesis.
Assuntos
Linhagem Celular Transformada , Ativação Linfocitária , Mucopolissacaridose II/diagnóstico , Linhagem Celular Transformada/citologia , Linhagem Celular Transformada/enzimologia , Transformação Celular Viral , Cerebrosídeo Sulfatase/metabolismo , Células Clonais/classificação , Feminino , Herpesvirus Humano 4 , Heterozigoto , Humanos , Iduronato Sulfatase/metabolismo , Masculino , MosaicismoRESUMO
A novel radioactive substrate for alpha-L-iduronidase, anhydro[3H]mannitol-iduronide has been prepared. This compound is hydrolysed by alpha-L-iduronidase to yield anhydro[3H]mannitol, which can be separated from the substrate and counted. The assay, described for use with fibroblast homogenates, is satisfactory for the diagnosis of mucopolysaccharidosis I.
Assuntos
Ensaios Enzimáticos Clínicos/métodos , Glicosídeo Hidrolases/metabolismo , Iduronidase/metabolismo , Dissacarídeos/síntese química , Fibroblastos/enzimologia , Humanos , Iduronidase/deficiência , Marcação por Isótopo , Manitol/síntese química , Mucopolissacaridoses/diagnóstico , TrítioRESUMO
We studied the residual alpha-N-acetylglucosaminidase activity in two siblings with severe and mild Sanfilippo B syndrome. No striking differences were demonstrated between the mutant enzymes from the severe and the mild case. However we found an altered enzyme activity characterized by displacement of the pH optimum towards basic values compared to the pH optimum of the normal enzyme, higher stability to heat and to Hg2+ ion treatment. It is suggested that the Sanfilippo B disease in this sibship is due to a mutation of a structural gene coding for alpha-N-acetylglucosaminidase.
Assuntos
Acetilglucosaminidase/metabolismo , Hexosaminidases/metabolismo , Mucopolissacaridoses/genética , Mucopolissacaridose III/genética , Acetilglucosaminidase/antagonistas & inibidores , Células Cultivadas , Estabilidade de Medicamentos , Fibroblastos/enzimologia , Temperatura Alta , Humanos , Concentração de Íons de Hidrogênio , Mercúrio/farmacologia , Mucopolissacaridose III/enzimologiaRESUMO
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a lysosomal disease caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS, EC 3.1.6.13). Affected patients show a wide spectrum of clinical phenotypes, from severe to mild. Mutational analysis on this disease resulted in the identification of more than 200 alterations. Bone marrow transplantation (BMT) is considered, at present, an appropriate therapy for MPS II subjects without severe neuropsychological impairment, however molecular analysis in BMT treated patients has been poorly studied. We describe here a patient subjected to BMT in 1995 whose IDS gene alteration, mutation P266H, was identified thereafter. The 4-year follow-up included clinical, biochemical and molecular parameters. DNA analysis showed, after BMT, coexisting host mutant and donor normal alleles, ensuring the effectiveness of the therapy and providing a fast and accurate tool to monitor the colonization of donor cells after treatment.